Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

Summary

This study is a phase III, multicenter, double-blind, placebo-controlled, parallel group comparative study to evaluate the efficacy and safety of Z-100 with primary uterine cervical cancer on radiotherapy. The study will use a central randomization with a dynamic allocation using biased coin minimization.

Timeline

Start

2014-12

Primary completion

2021-06-29

Completion

2022-02-25

Drugs

Indications